肾脏疾病
肾
纤维化
上皮-间质转换
KLF4公司
癌症研究
肾干细胞
基因敲除
生物
肾功能
病理
医学
下调和上调
内分泌学
细胞培养
细胞生物学
SOX2
转录因子
干细胞
基因
祖细胞
生物化学
遗传学
作者
Wa Zhou,Yan-Xia Chen,Ben Ke,Jiake He,Na Zhu,Afei Zhang,Xiangdong Fang,Weiping Tu
出处
期刊:Epigenomics
[Future Medicine]
日期:2022-02-01
卷期号:14 (4): 199-217
被引量:9
标识
DOI:10.2217/epi-2021-0370
摘要
Aims: The authors aim to investigate the function of circPlekha7 in renal fibrosis. Methods: Human renal tissues from chronic kidney disease patients, kidney cell line and primary cultured renal tubular epithelial cells were used. TGF-β1-treated human kidney 2 cells/tubular epithelial cells and a unilateral ureteral obstruction mouse model were employed to study renal fibrosis. Results: circPlekha7 was diminished in renal tissues from chronic kidney disease patients and TGF-β1-treated human kidney 2 cells and tubular epithelial cells, while miR-493-3p was upregulated. Overexpression of circPlekha7 or knockdown of miR-493-3p suppressed TGF-β1 induced enhancements on epithelial to mesenchymal transition and fibrogenesis, as well as attenuated renal fibrosis and injury in mice subjected to unilateral ureteral obstruction. circPlekha7 bound with miR-493-3p, which directly targeted KLF4. Conclusion: circPlekha7 inhibits epithelial to mesenchymal transition of renal tubular epithelial cells and fibrosis via targeting miR-493-3p to de-repress KLF4/mitofusin2 expression.
科研通智能强力驱动
Strongly Powered by AbleSci AI